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Introduction 
According to Cancer Research UK over the last 40 years’ prostate cancer incidence rates in 
UK have more than tripled. There were 47,300 new cases of prostate cancer diagnosed in 
the UK in 2013. It is the second most common cause of cancer in the UK and more than half 
the cases (54%) are in men 70 years of age and older causing around 11,300 deaths in the 
UK in 2014.  It has been estimated that worldwide more than 1.11 million men were 
diagnosed with prostate cancer resulting in more than307,000 deaths in 20121.  
The National Cancer Patient Experience Survey (NCPES) in England has demonstrated that 
patients with cancer who have access to a Clinical Nurse Specialist (CNS), generally report 
better experiences and understanding of the disease2-5. Despite the known benefits of 
access to a specialist nurse the distribution of specialist nurses and incidence-to-nurse ratios 
vary enormously indicating that there is an inequity of access. Unlike other cancers, prostate 
cancer nursing care in the UK is rarely provided by a prostate CNS6,7. This is corroborated by 
the national cancer nursing census which shows that only 2% of the specialist nursing 
workforce in England are prostate specific, approximately the same number as a rare cancer 
like sarcoma8.  
In the absence of a dedicated prostate cancer nursing workforce, prostate cancer care in the 
UK is provided by a variety of urology and uro-oncology nurses alongside specialists from 
other fields including bladder, kidney, testicular and penile cancer, as well as benign disease. 
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As a consequence, there are a variety of service arrangements and intersections with a 
number of multidisciplinary teams6,7. 
Cancer care in the UK is delivered by collaborative multidisciplinary teams (MDT) consisting 
of a core set of professionals which includes oncologists, surgeons and clinical nurse 
specialists9. In the UK patients are not generally present at MDT meetings. As this study was 
carried out in the UK NHS all staff are salaried and do not receive a fee for service. 
The national cancer peer review programme, launched in England in 2001, provided 
measurable standards to assess teams’ adherence to the best practice guidance9,10. These 
standards reflect best practice drawn from a combination of research evidence, national 
consensus, and expert opinion and central to this approach was the multidisciplinary team. 
The MDT was promoted as best practice in cancer care as a means of achieving more holistic 
cancer care delivered in a timely way by a team of experts rather than isolated individuals11.  
The impact of working in MDT on team members is not well understood12 and the limited 
body of knowledge appears to be contradictory. In a national survey of team members 
carried out in the UK in 2014 (n=2054) most respondents (90%) agreed that working in 
multidisciplinary teams was beneficial to the wellbeing of members, and 81% agreed that it 
improves job satisfaction13. There is, however, anecdotal evidence of autocratic practice and 
hierarchical boundaries making teams dysfunctional and participation stressful14. Interviews 
with MDT members in primary care (n=121) identified sources of conflict and barriers to 
conflict resolution, alongside team and individual strategies to resolve conflict15. However, 
an intervention study conducted with teams in General Internal Medicine did not achieve 
improvements in communication or collaboration due to lack of senior staff support or 
positive role modelling16, whilst an observational study revealed hierarchical behaviours in 
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inter-professional teams, despite team leaders (physicians) espousing collaborative 
leadership values17. Much of the research is focussed on the MDT meeting and its function 
or validity. A study of 370 MDT meetings18 which looked at different long term conditions 
including cancer found substantial diversity. This diversity existed in the purpose, structure, 
processes and content of MDT meetings. Greater multidisciplinary was not necessarily 
associated with more effective decision-making and MDT decisions (as measured by 
decision implementation). Decisions were also less likely to be implemented for patients 
living in more deprived areas18. There is little presented in the literature specifically about 
experiences of CNS in the multidisciplinary team however, the work of Taylor and Ramirez13 
for the National Cancer Action Team provided very detailed responses from cancer nurses 
as a subgroup. There appears to be no work on the experiences of specialist nurses working 
in uro-oncology who will also cover benign disease6.   
A detailed survey of the specialist uro-oncology nursing workforce6 was undertaken in 2014 
to look at many facets of the role and gather demographic information about the workforce 
providing care to men with prostate cancer in the UK. Specific questions about the 
experience of working in the MDT were included in the survey and respondents were 
offered the opportunity to share their experiences of MDT working through a free text 
option where respondents could add detail and depth to their responses. The original 
survey revealed a rich dataset of experiences of working within the MDT and these have 
been subjected to secondary analysis by the research team.   
Methods 
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A cross sectional survey was undertaken using a census of the workforce similar to that used 
in the specialist cancer workforce 19,20. A secondary analysis of a subset of the original data 
relating to experience of working in an MDT was then carried out.  
 
 
Sample 
This is a whole population sample study. The available population of specialist nurses 
working in uro-oncology was determined by the British Association of Urological Nurses 
(BAUN) membership and the previous national census8 to be between 300-350 by 
headcount. 
Data collection methods 
A 24-item survey questionnaire, exploring demographic data, caseload and workload and 
experience of MDT working was developed for this population by consensus using clinical, 
patient and academic experts7. The questionnaire was designed to gather data on activity 
and complexity of specialist nursing services provided including work left undone and used a 
format similar to the national optimum caseload modelling project 21. This was transferred 
to an online survey tool (administered using a Survey Monkey secure account).  Ethical 
approval was sought and granted by Plymouth University ethics committee. The survey was 
developed during April and May 2014 and pilot tested with a small sample from the study 
population. The survey link was distributed through formal and informal networks, mailing 
lists, the nursing press, targeted interest groups such as BAUN, NHS Contact, Help, Advice 
and Information Network (CHAIN), the UK Oncology Nursing Society (UKONS) and social 
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media (Twitter) during June and July of 2014. Participants could only submit a single 
response from each computer. Analysis of the survey took place in November2014-January 
2015. The secondary analysis of the original data7 used in this study took place in 
Autumn/Winter 2015. 
The survey presented a number of consensus statements. The respondents could choose to 
‘agree’ or not with each of the 24 statements.. Thirteen of the 24 survey items related to 
the respondents’ experience working in an MDT and are listed in Box 1. 
Box 1: The statements presented as options in the survey. 
 
 
 
 
 
 
 
 
 
 
 
 
The responses were examined overall and in addition by length of time in prostate cancer 
care and by pay band. Open, free text, questions were also included to allow participants to 
provide additional information on areas such as education, workload or any other issues 
they felt relevant 
• I work in a functional and efficient MDT 
• I work in a dysfunctional MDT where views are not respected 
• The MDT meeting pays attention only to medical issues 
• I am not always told of new patients by members of the MDT 
• Attending the MDT meeting is not applicable to my role 
• I do not attend the MDT meeting 
• I would constructively challenge all members of the MDT in the meeting 
• I would constructively challenge some members of the MDT in the meeting but not others 
• I would constructively challenge members of the MDT after the meeting/separately in private 
• I wait until after the meeting to challenge because there is not enough time during the meeting 
• There are some members of the team I feel uncomfortable challenging in or outside the meeting 
• I do not feel it’s my role to challenge other members of the MDT 
• I find the MDT meeting intimidating 
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Data analysis 
Data were exported into Excel and modelled using descriptive statistics for example 
demographics, payband and length of service.  Free text comments were analysed using 
thematic content analysis22. Thematic content analysis is the approach best suited to free 
text questions in an otherwise quantitative questionnaire as it does not rely on 
interpretation of data but instead reflects a ‘low hovering over the data’22. Each comment 
was coded and themes emerged from the codes. Data excerpts are included below 
alongside quantitative findings, to provide context. Excerpts are annotated according to job 
title and pay band (e.g. CNS/band 6). The secondary analysis presented here is confined to 
the subsection of the survey which examined the experience of working in the MDT. In 
order to determine if responses were equal across different sectors of the workforce, 
responses were broken down by pay band and by years of experience. These are reported 
below.  
Results 
There were 302 respondents in total. After cleaning, the data from 285 respondents were 
used. 17 records were removed as they were incomplete submissions or submissions from 
countries outside of the UK. Assuming the higher total of CNS working in uro-oncology in the 
UK to be 350 this suggests a response rate of 81% after data cleaning. The most common 
job title was Clinical Nurse Specialist (n= 185). The responses were further broken down by 
the ‘Agenda for Change’ payband of their post. ‘Agenda for Change’ is the process in the 
NHS by which nursing roles are allocated to one of nine pay bands on the basis of the 
knowledge, responsibility, skills and effort required for the post following a job evaluation. 
In general, the higher banding requires greater knowledge, responsibility and skills23.  The 
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most common band was Agenda for Change band seven (n= 174). However, in Scotland 50% 
of the respondents stated that they were paid on band six. Over half the respondents 
(n=158) had worked in prostate cancer care for more than 10 years. Few (n=48) had come 
into specialist posts from a specific specialist nurse development role. 
 
The results of the study are reported in full elsewhere6,7 and the results that specifically 
address working in the MDT are reported here. The MDT is a key component of cancer care 
delivery and is enshrined in English cancer policy24 however increasing workload and 
cultural differences appear to present barriers for effective MDT working. The breakdown of 
respondents by country is shown in Table 1. 
INSERT TABLE 1 HERE 
Table 1: Number of respondents by country. 
Overall responses to the survey 
The overall response to the survey can be seen in Figure 1. Two themes emerged from the 
results:  firstly the functionality and operation of the MDT and secondly the confidence or 
ability of the respondents to constructively challenge other members of the MDT. 
Quantitative findings are presented below in relation to these two themes; data excerpts 
from the free text responses are provided alongside the quantitative data. 
INSERT FIGURE 1 HERE 
Figure 1: Agreed statements about MDT meeting (number equals number of respondents 
out of 285 agreeing with the statement). 
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Functionality and operation of the MDT 
Less than half of respondents (n=128, 45%) agreed that they worked in a functional and 
efficient MDT. Respondents agreed that they worked in a dysfunctional MDT where views 
were not respected in 12% (n =35) of responses and 14% (n=40) agreed that the MDT 
meeting only paid attention to medical issues while 27% (n=76) agreed that they were not 
always told of new patients by members of the MDT. 
The free-text comments (n=42) were most extensive in the questionnaire, with most 
comments expressing concerns about conduct of the MDT meeting. Common areas of 
concern relate the lack of interest in non-medical concerns: 
 “I don’t feel my views are valued at the MDT; they certainly don’t ask for a nursing 
opinion” (CNS, band 7) 
 “The MDT is driven by medical diagnosis, due to the number of patients we have to 
discuss” (CNS, band 7) 
The most common issue expressed by the respondents is a lack of time – large numbers of 
patients are commonly discussed and problems such as ‘the consultant sometimes goes off-
script’ or ‘sometimes it can get quite heated ’were seen to contribute to the ineffective 
working of the MDT. The lack of buy-in at organisational level was reflected in one 
comment: 
[The MDT meeting is] often disorganised, poorly attended at consultant level. No 
team cohesion with clerical staff/management. Management do not respect the 
importance of MDT often double book the consultants which forces poor attendance 
(CNS, band 6) 
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The changes to cancer care delivery and multisite MDT meetings also presented challenges-
for example: 
“While our local MDT works well, there are conflicts and issues within the larger MDT 
which includes [name of hospitals] Hospitals. I would rarely speak up in these 
teleconference meetings. With the NHS changes and changes to the Cancer Networks 
the momentum for change and progress has been compromised” (Specialist Nurse, 
Band 6) 
When reviewed by pay band (see Table 2), the percentage of respondents agreeing that 
they worked in a functional and efficient MDT increased for each pay band (20% at Band 5, 
35% at Band 6, 49% at Band 7, 54% at Band 8a and 80% at Band 8b). The percentage of 
respondents agreeing that they worked in a dysfunctional MDT was relatively constant as 
was those who agreed that the MDT paid attention only to medical issues. 
INSERT TABLE 2 HERE 
Table 2: Agreed statements about MDT meeting by pay band. Percentages relate to the 
percentage of respondents at each band who agreed with the relevant statement. 
To see if responses were affected by the number of years’ experience the respondents have 
the responses were broken down into five categories by length of experience (Less than one 
year, 1 to 3 years, 4 to 6 years, 7 to 10 years and over 10 years) (see Table 3) There were 
only 11 responses from nurses with less than a year’s experience so it was difficult to draw 
any conclusions from this group. 
INSERT TABLE 3 HERE 
Table 3: Agreed statements about MDT meeting by years’ experience. Percentages relate to 
the percentage of respondents at each experience level who agreed with the relevant 
statement. 
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The percentage of nurses who agreed they worked in a functional and efficient MDT varied 
from the 57% for the 1 to 3, 37% for the 4 to 6, 47% for the 7 to 10 and 48% for the 10 years 
plus experience groups. However, looking at the number of nurses who agreed that they 
worked in a dysfunctional MDT there was a higher response (37%) from those with 4 to 6 
years’ experience than those with 1 to 3 years (10%), 7 to 10 years (9%) and 10 years plus 
(10%). 
As regards the MDT paying attention only to medical issues there was a relatively constant 
response between the experience groups (11% to 19%). When looking at respondents being 
told of new patients by members of the MDT there appears to be a divide between nurses 
with 1 to 3 or 4 to 6 years’ experience (33% and 32% respectively) being less likely to be 
informed of new patients compared to those with 7 to 10 or 10 years plus years’ experience 
(24% and 25% respectively). Positive responses to attending the MDT meeting not being 
part of their role and not attending the MDT meeting were very similar over all experience 
groups. 
Freedom to challenge 
Looking at the ability to constructively challenge other members of the MDT during the 
meeting 34% (n=97) respondents felt able to constructively challenge all members of the 
MDT during the meeting. While 23% (n=66) felt able to constructively challenge some 
members of the MDT in the meeting but not others in20% of responses they (n=57) agreed 
that there were some members of the team they felt uncomfortable challenging in or out of 
the meeting and 4% (n=10) found the meeting intimidating. Only 2% (n=6) agreed that it 
was not their role to challenge other members of the MDT. As regards challenging after the 
meeting 21% (n=61) agreed that they would constructively challenge members of the MDT 
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after the meeting or separately in private while 10% (n=30) agreed that they would wait 
until after the meeting as there was not enough time in the meeting.  
 
Another theme that emerged from the free text responses was the ability to constructively 
challenge decisions or views within the MDT meeting 
“MDT can be difficult, I would usually challenge during the MDT, but don't always get 
heard, either due to the general discussion (sometimes quite heated) I feel ignored 
though sometimes, I don't have access to all MDT members to challenge outside the 
MDT meeting. Within the meeting however, I think I have more of a voice than the 
other nurse members, I suspect they challenge some individuals outside the meeting. 
I believe I am there to advocate on behalf of patients and hope if ever I needed 
discussed in an MDT the CNS would speak up for me” (CNS, band 7) 
“It would depend on who was at the MDT as dynamics change when certain 
members are not there” (CNS, Band 6) 
Finally, 9% (n=25) agreed that attending the MDT meeting was not applicable to their role 
while 11% (n=34) did not attend the MDT meeting. 
Responses were reviewed by pay band (see Table 2). Looking at the ability to constructively 
challenge all members of the MDT in the meeting there is an increase in the percentage 
agreeing with this statement with increasing band after 6 (20% at Band 5, 20% at Band 6, 
37% at Band 7, 46% at Band 8a and 100% at Band 8b) while the percentage of respondents 
agreeing that there are some members of the team they feel uncomfortable challenging is 
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relatively constant across bands 5 to 8a (20% at Band 5, 20% at Band 6, 22% at Band 7 and 
14% at Band 8a) (see Table 2). 
Responses were also reviewed by years of experience (see table 3). There is again an 
observed difference between those with 1 to 3 or 3 to 6 years’ experience (24% and 18% 
respectively) and those with 7 to 10 or 10 years plus experience (34% and 42% respectively) 
with the longer service band feeling abler to challenge. Those with 1 to 3 or 4 to 6 years’ 
experience were more likely to agree that they would challenge some members of the MDT 
in the meeting but not others (33% and 34% respectively) compared to those with 7 to 10 or 
10 years plus experience (23% and 20% respectively). The rate of agreeing that there were 
some members of the team they felt uncomfortable challenging in or out of the meeting 
was consistent among the 1 to 3, 4 to 6 and 7 to 10 years’ experience groups (28%, 26% and 
24%) and slightly reduced in the 10 years plus group (15%). The responses to not feeling it 
was part of their role to challenge in the MDT meeting and finding the MDT meeting 
intimidating were similar across all experience groups. 
 
Discussion 
The results obtained in this study demonstrate that there is a variety of perceptions of the 
experience of working in MDT across urology nurses in the UK. As the MDT is a cancer 
standard in England with a proscribed membership the MDT meetings are often large and 
many patients are reviewed. A number of studies have been carried out into the 
effectiveness of MDT meetings and the contribution of nurses to the MDT meeting since 
MDT were introduced. 
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Atwal and Caldwell25 looked at nurse’s perceptions of MDT work in acute health care.  They 
reported that three barriers hindered teamwork: (i) differing perceptions of teamwork (ii) 
different levels of skills acquisitions to function as a team member and (iii) the dominance of 
medical power that influenced interaction in teams. 
A study by Fosker and Dodwell looked at attendances, time spent on the MDT meeting and 
the number of patients discussed in the MDT for 14 cancer MDT over a single week. The 
results obtained showed that an average of 10 consultants, less than one junior doctor 
(0.7/meeting) and 3 ‘others’ (nurses, pharmacy staff, radiographers and clerical) attended 
each meeting. An average of 31 patients were discussed at each MDT and the average time 
allocated was 2.14 hours (around 4 minutes per patient). The time spent did not include 
preparation time26.   
Lamb et al analysed the contributions of surgeons, oncologists, radiologists, pathologists 
and clinical nurse to MDT and reported that surgeons and radiologists had above average 
contributions compared to histopathologists and nurses which were rated below average27. 
Other studies have found that the CNS is often the team member assessing the holistic 
needs of the patient and acting as the key worker28 and the same group reported that 
nurse’s contributions to MDT meetings may be limited27. 
Patient involvement in treatment decisions is central to UK health policy and a key part of 
the NHS constitution with the phrase ‘No decision about me without me’ being used to 
describe the importance of the patient viewpoint. Taylor and Green carried out a qualitative 
interview study looking at ‘No decision about me without me’ in the context of MDT 
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meetings. The researchers conducted semi-structured interviews with 9 current cancer care 
patients and 12 MDT members from the teams managing their care. Findings showed that 
most MDT members felt the patients had a limited understanding about the MDT and that 
at most they might understand that recommendations for treatment were the result of an 
MDT discussion between groups of different health professionals. Three patients in the 
study recalled being given information about the MDT verbally by the CNS and members of 
the MDT described the importance of the CNS in relation to information giving due to their 
level of contact with the patient. The study also reported instances where patients were 
presented at the MDT without team members having prior knowledge of them and 
suggested that if nobody in the MDT knows the patient it was more likely that the treatment 
plan would not be correct29. 
 
Eigenmann, in a personal view, suggests that crucial decisions are often made in the MDT 
without seeing the patient and suggests that the MDT should always include an advocate for 
the patient such as the patient’s general practitioner or a hospital generalist. He further 
states that the opinion of the patient through his or her advocate should carry the same 
weight as specialist opinion30.  
MDT working should facilitate excellence through collaborative working and be the 
cornerstone for patient centred care. However, the poor experience of MDT working and 
meetings reported by many nurses in this study is very concerning with less than half of the 
respondents agreeing that they worked in a functional and efficient MDT. Lack of time, 
disorganisation and the high numbers of patients to be discussed were all reported as 
barriers to efficient MDT working. The ability of nurses to challenge in the MDT meeting is 
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also very important as all members of the MDT team should feel able to challenge in the 
meeting if appropriate but again our findings give cause for concern. All members of the 
MDT should feel able to challenge in the meeting if appropriate yet around a quarter of 
nurses reported that there were some members of the MDT they felt uncomfortable 
challenging in or out of the meeting.  
Patient advocacy is a significant part of the role of CNS and many prostate CNS are 
instrumental in helping patients come to decisions regarding their treatment options as well 
as managing the after effects of these treatments. The American Association of Critical-Care 
Nursing Scope and Standards of Professional Standards for the Acute and Critical Care Nurse 
Specialist Practice report recommends that advocacy, communication and responding to 
diversity are key roles of the CNS31 and this is emphasised by Gurzick and Kesten who 
looked at the impact of CNS on clinical pathways with regard to the application of evidence 
based practice32.  
Therapies for prostate cancer often result in significant quality of life issues which can 
impact on their survivorship long after treatment has ended. In addition, men with relapsing 
or progressing illness often have very significant physical, psychological and social issues 
which need to be taken into account in treatment paths. Several studies have demonstrated 
the vital role the CNS can play to identify these issues33 and ensuring that they are 
addressed when formulating care plans. Another area in which the CNS can have an 
important impact is in facilitating family intervention for prostate cancer patients as many of 
the issues facing men with prostate cancer impact on spouses as well as the patient34. 
Again, the results of this study suggest that there is a need for these issues to be taken into 
account and that this may not always be the case at present with 14% of the respondents 
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agreeing that the MDT only took account of medical issues and 27% agreeing that they were 
not always told of new patients before the MDT. This may make it difficult to present non-
medical issues even though the CNS is often the most appropriate member of the team to 
do this. 
Conclusion 
It is apparent that many of the issues raised by previous studies which repeatedly arise into 
the experience of nurses at MDT and their contribution to the MDT still need to be 
addressed. It is recommended that all teams review the time allocated for MDT to ensure 
there is adequate dedicated time both to present each patient and for preparation. As 
regards preparation all cases to be discussed at the MDT should have the appropriate 
information collected and collated prior to the MDT, perhaps in the form of a proforma 
which would include information such as the patient demographics, their diagnosis, 
suggested treatment regimes, the patients’ individual preferences and any co-morbidities. 
This information should be distributed to all members of the MDT prior to the meeting. This 
time for presentation and preparation should be protected for all members of the MDT. The 
wider body of evidence cited here indicates that this needs to be addressed at 
organisational level, as well as by the local teams. 
The structure of meetings should also be reviewed to ensure that all members’ 
contributions are heard and valued. More emphasis needs to be given to patient’s non-
medical needs to ensure that ‘No decision about me without me without me’ becomes a 
reality rather than a catch-phrase and it is believed by the authors of this study that the CNS 
is the most appropriate person to represent the patient’s views in the MDT given that they 
tend to have the most contact with the patient. This would have a significant impact on 
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patient care and experience and also utilise the skills and abilities of the CNS increasing their 
job satisfaction. The increased emphasis on inter-professional learning includes teamwork 
as a key theme; our findings suggest that this needs to move beyond undergraduate 
curricula and become embedded into mandatory training and education35. This is also a 
fruitful area for future research. 
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